Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,474 | 18,122 | 6,401 | 11,782 | 18,076 |
| Receivables | 83 | 1,746 | 2,083 | 2,402 | 1,681 |
| Other current assets | 0 | 0 | 0 | 586 | 0 |
| TOTAL | $19,487 | $21,956 | $10,913 | $16,619 | $22,423 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 11,702 | N/A | 13,060 |
| Other Non-Current Assets | 0 | 0 | 5,326 | 17,803 | 5,632 |
| TOTAL | $N/A | $N/A | $17,028 | $17,803 | $18,692 |
| Total Assets | $19,487 | $21,956 | $27,941 | $34,422 | $41,115 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,304 | 2,661 | 4,539 | 2,521 | 5,746 |
| TOTAL | $2,780 | $2,921 | $5,204 | $7,782 | $11,287 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 108 | N/A | N/A | N/A | 5,050 |
| Other Non-Current Liabilities | 0 | 0 | 6,824 | 7,039 | 7,226 |
| TOTAL | $N/A | $N/A | $6,824 | $7,039 | $7,226 |
| Total Liabilities | $2,780 | $2,921 | $12,028 | $14,821 | $18,513 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,889 | 8,809 | 8,799 | 8,799 | 8,360 |
| Common Shares | 9 | 9 | 9 | 8 | 84 |
| Retained earnings | -433,483 | -430,501 | -433,017 | -428,049 | -424,193 |
| TOTAL | $16,707 | $19,035 | $15,913 | $19,601 | $22,602 |
| Total Liabilities And Equity | $19,487 | $21,956 | $27,941 | $34,422 | $41,115 |